| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC1432 |
| Trial ID | NCT01686334 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | WT1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | WT1-RNA DC Vaccine |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial |
| Year | 2012 |
| Country | Belgium |
| Company sponsor | Zwi Berneman |
| Other ID(s) | CCRG12-001 |
| Vector information | |||
|
|||
| Cohort1: DC vaccine | |||||||
|
|||||||
| Cohort2: No Intervention | |||||||
|
|||||||